It has been shown that melatonin inhibits the formation of soluble APP in vitro, which in turn could prevent Aβ production (Lahiri, 1999), consistent with the decrease in APP mRNA level after melatonin administration in P12 cells, but not in human neuroblastoma cells (Song & Lahiri, 1997). The gene discussed is APP; the disease is neuroblastoma.